ATE71107T1 - Steroide zur verwendung als mittel gegen krebs und fettsucht, therapeutische zusammensetzungen, die dies enthalten und ihre anwendung zur herstellung einer therapeutischen zusammensetzung. - Google Patents
Steroide zur verwendung als mittel gegen krebs und fettsucht, therapeutische zusammensetzungen, die dies enthalten und ihre anwendung zur herstellung einer therapeutischen zusammensetzung.Info
- Publication number
- ATE71107T1 ATE71107T1 AT87107411T AT87107411T ATE71107T1 AT E71107 T1 ATE71107 T1 AT E71107T1 AT 87107411 T AT87107411 T AT 87107411T AT 87107411 T AT87107411 T AT 87107411T AT E71107 T1 ATE71107 T1 AT E71107T1
- Authority
- AT
- Austria
- Prior art keywords
- preparation
- cancer
- therapeutic composition
- steroids
- compositions containing
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 230000001225 therapeutic effect Effects 0.000 title abstract 4
- 208000008589 Obesity Diseases 0.000 title 1
- 230000001093 anti-cancer Effects 0.000 title 1
- 230000003579 anti-obesity Effects 0.000 title 1
- 235000020824 obesity Nutrition 0.000 title 1
- 150000003431 steroids Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000003712 anti-aging effect Effects 0.000 abstract 1
- 239000000883 anti-obesity agent Substances 0.000 abstract 1
- 239000003529 anticholesteremic agent Substances 0.000 abstract 1
- 239000003472 antidiabetic agent Substances 0.000 abstract 1
- 229940125710 antiobesity agent Drugs 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 208000029078 coronary artery disease Diseases 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
- C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
- C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
- C07J1/0025—Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/005—Ketals
- C07J21/008—Ketals at position 17
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
- C07J41/0016—Oximes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
- C07J53/004—3 membered carbocyclic rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86711286A | 1986-05-21 | 1986-05-21 | |
| EP87107411A EP0246650B1 (de) | 1986-05-21 | 1987-05-21 | Steroide zur Verwendung als Mittel gegen Krebs und Fettsucht, therapeutische Zusammensetzungen, die dies enthalten und ihre Anwendung zur Herstellung einer therapeutischen Zusammensetzung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE71107T1 true ATE71107T1 (de) | 1992-01-15 |
Family
ID=25349110
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT87107411T ATE71107T1 (de) | 1986-05-21 | 1987-05-21 | Steroide zur verwendung als mittel gegen krebs und fettsucht, therapeutische zusammensetzungen, die dies enthalten und ihre anwendung zur herstellung einer therapeutischen zusammensetzung. |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0246650B1 (de) |
| JP (1) | JP2566574B2 (de) |
| AT (1) | ATE71107T1 (de) |
| AU (1) | AU601184B2 (de) |
| CA (1) | CA1329195C (de) |
| DE (1) | DE3775617D1 (de) |
| DK (1) | DK173168B1 (de) |
| ES (1) | ES2039373T3 (de) |
| GR (1) | GR3003769T3 (de) |
| IE (1) | IE60027B1 (de) |
| NO (1) | NO173278C (de) |
| PT (1) | PT84911B (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5585371A (en) * | 1990-08-29 | 1996-12-17 | Humanetics Corporation | Treatment of immune system with Δ5-androstenes |
| US5506223A (en) * | 1990-08-29 | 1996-04-09 | Humanetics Corporation | Δ5-androstenes useful for promoting weight maintenance or weight loss and treatment process |
| DK0547151T3 (da) * | 1990-08-29 | 2003-03-17 | Humanetics Corp | Behandlingsmåde til fremme af vægttab under anvendelse af et substitueret delta-5-androsten |
| JPH0684398B2 (ja) * | 1990-08-31 | 1994-10-26 | 雪印乳業株式会社 | 新規なアンドロステン誘導体及びそれを用いる６‐アルキルカルボニルオキシ‐１４α‐ヒドロキシ‐アンドロスト‐４，６‐ジエン‐３，１７‐ジオンの製造法 |
| JP2004510781A (ja) * | 2000-10-06 | 2004-04-08 | イーソン セラピューティクス インコーポレイテッド | 高トリグリセリド血症の治療に有用な化合物 |
| EP1499338A4 (de) * | 2002-05-01 | 2008-06-18 | Arthur Schwartz | 7-hydroxy-16alpha-fluor-5-androsten-17-one und 7-hydroxy-16alpha-fluor-5-androstan-17-one und ihre derivate |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1314870C (en) * | 1983-08-02 | 1993-03-23 | Arthur G. Schwartz | Steroids useful as anti-cancer, anti-obesity, anti-hyperglycemic, anti-autoimmune and anti-hypercholesterolemic agents |
| AU598201B2 (en) * | 1985-08-02 | 1990-06-21 | Research Corporation | Steroids useful as anti-cancer, anti-obesity, anti-hyperglycemic, anti-autoimmune and anti-hypercholesterolemic agents |
| JP2920854B2 (ja) * | 1991-08-01 | 1999-07-19 | 富士通株式会社 | ビィアホール構造及びその形成方法 |
-
1987
- 1987-05-20 IE IE131287A patent/IE60027B1/en not_active IP Right Cessation
- 1987-05-20 AU AU73296/87A patent/AU601184B2/en not_active Ceased
- 1987-05-20 PT PT84911A patent/PT84911B/pt not_active IP Right Cessation
- 1987-05-20 NO NO872115A patent/NO173278C/no not_active IP Right Cessation
- 1987-05-21 DE DE8787107411T patent/DE3775617D1/de not_active Expired - Lifetime
- 1987-05-21 CA CA000537597A patent/CA1329195C/en not_active Expired - Fee Related
- 1987-05-21 DK DK198702593A patent/DK173168B1/da not_active IP Right Cessation
- 1987-05-21 ES ES198787107411T patent/ES2039373T3/es not_active Expired - Lifetime
- 1987-05-21 EP EP87107411A patent/EP0246650B1/de not_active Expired - Lifetime
- 1987-05-21 JP JP62126850A patent/JP2566574B2/ja not_active Expired - Fee Related
- 1987-05-21 AT AT87107411T patent/ATE71107T1/de not_active IP Right Cessation
-
1992
- 1992-02-11 GR GR920400191T patent/GR3003769T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPS62283993A (ja) | 1987-12-09 |
| PT84911B (pt) | 1990-02-08 |
| DK173168B1 (da) | 2000-02-28 |
| EP0246650B1 (de) | 1992-01-02 |
| IE871312L (en) | 1987-11-21 |
| NO872115L (no) | 1987-11-23 |
| EP0246650A1 (de) | 1987-11-25 |
| NO173278C (no) | 1993-12-01 |
| AU7329687A (en) | 1987-11-26 |
| ES2039373T3 (es) | 1993-10-01 |
| DE3775617D1 (de) | 1992-02-13 |
| AU601184B2 (en) | 1990-09-06 |
| IE60027B1 (en) | 1994-05-18 |
| PT84911A (en) | 1987-06-01 |
| NO173278B (no) | 1993-08-16 |
| CA1329195C (en) | 1994-05-03 |
| NO872115D0 (no) | 1987-05-20 |
| DK259387D0 (da) | 1987-05-21 |
| DK259387A (da) | 1987-11-22 |
| JP2566574B2 (ja) | 1996-12-25 |
| GR3003769T3 (de) | 1993-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE42959T1 (de) | Tigogenin-cellobioside und ihr hepta-azetat, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die tigogenin- cellobioside enthalten. | |
| ES8706717A1 (es) | Metodo de preparar esteroides | |
| KR900700486A (ko) | 신규한 벤조피리도 피페리딘, 피페리딜리덴 및 피페라진 화합물, 조성물, 제조방법 및 이용방법 | |
| CA2124932A1 (en) | Sex steroid activity inhibitors | |
| ATE1814T1 (de) | 9-hydroxyalkylpurine, verfahren zu ihrer herstellung und 9-hydroxyalkylpurine als aktive mittel enthaltende therapeutische zusammensetzung. | |
| US4978523A (en) | Melanin inhibitor | |
| DE59005254D1 (de) | 24-Homo-Vitamin-D-Derivate, Verfahren zu ihrer Herstellung; diese Derivate enthaltende pharmazeutische Präparate sowie deren Verwendung als Arzneimittel. | |
| DE69015736D1 (de) | 7-Keto- und 7-Hydroxy-androsta-3,5-dien-3-carbonsäure Derivate. | |
| DE69829279D1 (de) | Vitamin-d3?-derivate und aus diesen hergestellte heilmittel gegen entzündliche erkrankungen der atemwege | |
| DE3775617D1 (de) | Steroide zur verwendung als mittel gegen krebs und fettsucht, therapeutische zusammensetzungen, die dies enthalten und ihre anwendung zur herstellung einer therapeutischen zusammensetzung. | |
| FR2706454B1 (fr) | Nouveaux 19-Nor stéroïdes, procédé et intermédiaires de préparation, application comme médicaments et compositions pharmaceutiques les contenant. | |
| KR910000711A (ko) | 크로만 유도체 | |
| ATE193531T1 (de) | Phenyl-carboxamide-isoxazole-derivate und salze, verfahren zu ihrer herstellung ihre anwendung als arzneimittel und pharmazeutische zusammensetzungen die sie enthalten | |
| US4070450A (en) | Sunscreening compound and method | |
| ATE42561T1 (de) | In position 10 durch ein eine doppel- bzw. dreifachbindung enthaltendes radikal substituierte neue steroide, verfahren zu ihrer herstellung, ihre anwendung als heilmittel und diese enthaltende pharmazeutische praeparate. | |
| DE60043295D1 (de) | Chromanol glycoside zur behandlung von durch ultraviolettes licht verursachten dermopathien | |
| EP0278384A3 (de) | Alkohole und Ether mit Cyclododecyl- und Cyclododecenylgruppen, deren Herstellung und Verwendung als Duftstoffe | |
| ATE15370T1 (de) | 3-piperidinyl-indole derivate, ihre salze, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende arzneimittel. | |
| KR880007070A (ko) | 백내장 치료용 약학 조성물 | |
| ATE16108T1 (de) | Steroide die, in stellung 17 verestert sind, und in stellung 21 eine thioestergruppe enthalten, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel. | |
| EP0596450A1 (de) | Amid-Derivate und äusserliches Haupflegepräparat, die diese enthalten | |
| BR9507135A (pt) | Composto uso do mesmo processo de preparação do mesmo composição farmacêutica e composição cosmética | |
| SE8104393L (sv) | Llalfa-amino-androstaner | |
| ATE4720T1 (de) | Neue derivate von cardenolid-bis-digitoxosiden, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
| ATE56709T1 (de) | Phenylpyrazinderivate, verfahren zu deren herstellung, pharmazeutische zusammensetzung und verwendung. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |